Myricetin alleviated immunologic contact urticaria and mast cell degranulation via the PI3K /Akt/ NF‐κB pathway
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Shiting Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xi'an Jiaotong University, Xi'an, People's Republic of China. Hauptthemen laut MEDLINE: NF-kappa B, Urticaria. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, The Fundamental Research Funds for Central University and the Foundation from the Shaanxi Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Immunologic contact urticaria (ICU) is characterized by the wheal and flare reaction from direct contact with a chemical or protein agent, which involves a type I hypersensitivity mediated by allergen‐specific immunoglobulin E (sIgE). Myricetin (Myr), a bioactive flavonoid, exhibits antiinflammatory activities. Our results showed that treatment with Myr could alleviate ICU symptoms, including a decrease in the number of wheals and scratching, and inhibit ear swelling in the IgE/DNFB‐induced mice. The serum level of IgE, histamine, interleukin (IL)‐4, TNF‐α, and MCP‐1 were reduced in Myr‐treated mice. Myr also attenuated mast cells (MCs) degranulation and H‐PGDS, TSLP, IL‐33, PI3K, Akt, and NF‐κB mRNA levels in ICU model. The IgE‐mediated anaphylaxis mouse models demonstrated anti‐allergic effects of Myr. In vitro analysis showed that Myr reduced IgE‐induced calcium (Ca 2+ ) influx, suppressed degranulation, and chemokine release in LAD2 cells (human primary mast cells). Myr can significantly inhibited PLCγ1, Akt, NF‐κB, and p38 phosphorylation. In conclusion, the study demonstrated that Myr alleviate ICU symptoms and inhibit mast cell activation via PI3K/Akt/NF‐κB signal pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, People's Republic of China.
- Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
- Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
ORCID-Profile: Shiting Hu, Yuejing Wang, Hongli An
Förderung
- National Natural Science Foundation of China
- The Fundamental Research Funds for Central University and the Foundation from the Shaanxi Administration of Traditional Chinese Medicine
Zitieren
APA
Hu, S., Zhang, Y., Dang, B., Wang, Y., Zheng, G., Zhang, T., & An, H. (2023). Myricetin alleviated immunologic contact urticaria and mast cell degranulation via the PI3K /Akt/ NF‐κB pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.7726
Vancouver
Hu S, Zhang Y, Dang B, Wang Y, Zheng G, Zhang T, et al. Myricetin alleviated immunologic contact urticaria and mast cell degranulation via the PI3K /Akt/ NF‐κB pathway. Phytotherapy Research. 2023. doi:10.1002/ptr.7726
BibTeX
@article{Hu2023,
author = {Hu, Shiting and Zhang, Yonghui and Dang, Baowen and Wang, Yuejing and Zheng, Guodong and Zhang, Tao and An, Hongli},
title = {Myricetin alleviated immunologic contact urticaria and mast cell degranulation via the PI3K /Akt/ NF‐κB pathway},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7726}
}
EUVIMED